IL6 and congenital rubella syndrome: In particular, the levels of IL-6 seemed to be the most sensitive marker in view of an evident increase in plasmatic IL-6 observed in five patients (N° 1, 4, 8, 11, and 15; Supplementary Table S1A) who witnessed a clinical CRS following CAR-T-cell infusion.